Since TP53 mutations are known to contribute to the progression of pancreatic cancer [6,7], the detection of TP53 mutations in tumor tissues probably indicates the progression of the cancer cells, compared to TP53 wild-type tumors. Here, TP53 is linked to familial pancreatic carcinoma.